One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/S0167-8140(24)00019-7
Volume 190, January 2024, 110098
Clinical research for global needs of radiation oncology
Michael Baumann*, Carol Bacchus
doi : 10.1016/j.radonc.2023.110076
Volume 190, January 2024, 110076
Brachytherapy is an effective and safe salvage option for re-irradiation in recurrent glioblastoma (rGBM): A systematic review
Xiaoyong Xiang a, Zhe Ji c, Jing Jin
doi : 10.1016/j.radonc.2023.110012
Volume 190, January 2024, 110012
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis
Giulio Francolini a,*, Arunangshu Ghoshal b, Saverio Caini c, Tessa Piazzini d, Carlotta Becherini a, Beatrice Detti a, Vanessa Di Cataldo a, Marianna Valzano e, Luca Visani f, Viola Salvestrini f, Emanuela Olmetto a, Isacco Desideri e, Icro Meattini e, Lorenzo Livi
doi : 10.1016/j.radonc.2023.110038
Volume 190, January 2024, 110038
Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis
Baijie Feng a,b,1, Yue Zheng a,1, Jiayuan Zhang c, Min Tang a, Feifei Na
doi : 10.1016/j.radonc.2023.110014
Volume 190, January 2024, 110014
Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)
Fabio L. Cury a,*, Gustavo A. Viani b,1, Andre G. Gouveia c, Camila V.S. Freire d, Gabriel de A. Grisi d, Fabio Y. Moraes
doi : 10.1016/j.radonc.2023.109935
Volume 190, January 2024, 109935
Brain metastasis tumor segmentation and detection using deep learning algorithms: A systematic review and meta-analysis
Ting-Wei Wang a,b, Ming-Sheng Hsu b, Wei-Kai Lee a, Hung-Chuan Pan d,e, Huai-Che Yang b,c, Cheng-Chia Lee b,c, Yu-Te Wu
doi : 10.1016/j.radonc.2023.110007
Volume 190, January 2024, 110007
Recommendation on the technical and dosimetric data to be included in stereotactic body radiation therapy clinical trial publications based on a systematic review
Nicholas Hardcastle a,1, Mirjana Josipovic b,n,1, Enrico Clementel c, Victor Hernandez d, Gregory Smyth e, Manuela Gober f, Lotte Wilke g, David Eaton h, St´ephanie Josset i, Smaro Lazarakis a, Jordi Saez j, Laure Vieillevigne k, N?ria Jornet l,*, Pietro Mancosu
doi : 10.1016/j.radonc.2023.110042
Volume 190, January 2024, 110042
Real-time motion management in MRI-guided radiotherapy: Current status and AI-enabled prospects
Elia Lombardo a, Jennifer Dhont b,c, Denis Page d, Cristina Garibaldi e, Luise A. Künzel f,g,h, Coen Hurkmans i, Rob H.N. Tijssen i, Chiara Paganelli j, Paul Z.Y. Liu k,l, Paul J. Keall k,l, Marco Riboldi m, Christopher Kurz a, Guillaume Landry a,n,o, Davide Cusumano p, Marco Fusella q,*, Lorenzo Placidi
doi : 10.1016/j.radonc.2023.109970
Volume 190, January 2024, 109970
Modeling frameworks for radiation induced lymphopenia: A critical review
Laura Cella a,*, Serena Monti a, Roberto Pacelli b, Giuseppe Palma
doi : 10.1016/j.radonc.2023.110041
Volume 190, January 2024, 110041
Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline
R.S. Guninski a,*, F. Cuccia b, F. Alongi c, N. Andratschke a, C. Belka d, D. Bellut e, M. Dahele f, M. Josipovic g,h, T.E. Kroese a, P. Mancosu i, G. Minniti j, M. Niyazi q, U Ricardi k, P. Munck af Rosenschold l,m, A. Sahgal n, Y. Tsang o, W.F.A.R. Verbakel p, M. Guckenberger
doi : 10.1016/j.radonc.2023.109969
Volume 190, January 2024, 109969
ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases
M Guckenberger a,*, N Andratschke a, C Belka b,c,d, D Bellut e, F Cuccia f, M Dahele g, RS Guninski a, M Josipovic h,i, P Mancosu j, G Minniti k,s, M Niyazi t, U Ricardi l, P Munck af Rosenschold m, A Sahgal n, Y Tsang o, WFAR Verbakel p, F Alongi
doi : 10.1016/j.radonc.2023.109966
Volume 190, January 2024, 109966
The first clinical implementation of real-time 6 degree-of-freedom image-guided radiotherapy for liver SABR patients
Chandrima Sengupta a,*, Doan Trang Nguyen a, Trevor Moodie b, Daniel Mason c, Jianjie Luo c, Trent Causer c, Sau Fan Liu d, Elizabeth Brown d, Lauren Inskip b, Maryam Hazem c, Menglei Chao c, Tim Wang b, Yoo Y. Lee d, Kirsten van Gysen c, Emma Sullivan b, Eireann Cosgriff b, Prabhakar Ramachandran d, Per Poulsen e,f, Jeremy Booth g,h, Ricky O’Brien a,i, Peter Greer j, Paul Keall
doi : 10.1016/j.radonc.2023.110031
Volume 190, January 2024, 110031
Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer
H.R. Mortensena,i,1, P. Populaireb,m,1, L. Hoffmannc,i, D.S. Moellerc,i, A. Appeltd, P. Nafteuxe, C.T. Muijsf, C. Graua, M.A. Hawkinsg, E.G. C. Troosth,o, G. Defraenem, R. Cantersj, C.S. Clarken, D.C. Weberk,l, E. W. Korevaarf, K. Haustermansb,m,2, M. Nordsmarkc,2, Val Gebskip, M. P. Achiamq, Sheraz R. Markarr,s, Ganesh Radhakrishnat, Maaike Berbeeu, Daniele Scartoniv, Ester Orlandiw, Jerome Doyenx, Vincent Gregoirey, Gilles Crehangez, Johannes Langendijkaa, Paula Lorgellyab, Hedwig M. Blommensteinac,ad, Camilla S. Byskovae, Mai L. Ehmsenaf, Maria Fuglsang Jensenaf, Gloria Vilches Freixasag, Rebecca Bütoftah, The PROTECT consortium
doi : 10.1016/j.radonc.2023.109980
Volume 190, January 2024, 109980
The rise of negative portrayals of radiation oncology: A textual analysis of media news
Dominik Wawrzuta a,*, Justyna Klejdysz b,c, Marzanna Chojnacka
doi : 10.1016/j.radonc.2023.110008
Volume 190, January 2024, 110008
Omission of radiation therapy after breast-conserving surgery for biologically favourable tumours in younger patients: The wrong answer to the right question
Icro Meattinia,b,*, Gustavo Nader Martac,d, Susan Carrolle,f, Sofia Riverag,h, Gillian Lamourye,f, Francesca De Feliceg, Matteo Lambertinih,i, Lorenzo Livia,b, Orit Kaidar-Personj,k,l, Philip Poortmans
doi : 10.1016/j.radonc.2023.110045
Volume 190, January 2024, 110045
LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy
Timothy J. Whelan a,*, Anthony Fyles b, Sameer Parpia c, Torsten Nielsen d, Mark N. Levine
doi : 10.1016/j.radonc.2023.110074
Volume 190, January 2024, 110074
Introduction of ultra-hypofractionation in breast cancer: Implications for costs and resource use
Sara-Lise Busschaert a,*, Eva Kimpe a, Kurt Barb´e a, Mark De Ridder b, Koen Putman a,b
doi : 10.1016/j.radonc.2023.110010
Volume 190, January 2024, 110010
Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis
Kangpyo Kim a,1,2, Dongryul Oh a,1,2, Jae Myoung Noh a, Yang Won Min b, Hong Kwan Kim c, Yong Chan Ahn
doi : 10.1016/j.radonc.2023.109982
Volume 190, January 2024, 109982
External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts
M. Berb´ee a,1,*, C.T. Muijs b,1, F.E.M. Voncken c, L. Wee a, M. Sosef d, B. van Etten e, J.W. van Sandick f, F.A.R.M. Warmerdam g, J.J. de Haan h, E. Oldehinkel b, J.M. van Dieren i, L. Boersma a, J.A. Langendijk b, A. van der Schaaf b, J.B. Reitsma j, E. Schuit
doi : 10.1016/j.radonc.2023.109979
Volume 190, January 2024, 109979
Immune profiling of pancreatic cancer for radiotherapy with immunotherapy and targeted therapy: Biomarker analysis of a randomized phase 2 trial
Xiaofei Zhu a,1, Wenyu Liu b,1, Yangsen Cao a,1, Zhiru Feng a,1, Xianzhi Zhao a, Lingong Jiang a, Yusheng Ye a, Huojun Zhang
doi : 10.1016/j.radonc.2023.109941
Volume 190, January 2024, 109941
Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer
J. Friborg a,b,*, K. Jensen a, J.G. Eriksen c,d, E. Sams?e e, C. Maare f, M. Farhadi e, P. Sibolt f, M. Nielsen h, M. Andersen h, A.I.S. Holm c, P. Skyt a, B. Smulders a,b, J. Johansen g, J. Overgaard d, C. Grau a, C.R. Hansen
doi : 10.1016/j.radonc.2023.109958
Volume 190, January 2024, 109958
Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35
Christian R?nn Hansen a,b,c,?, Kenneth Jensen c , Bob Smulders c,d , Anne Ivalu Sander Holm e , Eva Sams?e c,f , Martin Skovmos Nielsen g , Patrik Sibolt h , Peter Skyt c , Ulrik Vindelev Elstr?m c , Camilla Panduro Nielsen a,b , J?rgen Johansen i , Ruta Zukauskaite b,i , Jesper Grau Eriksen e,j , Mohamma Farhadi f , Maria Andersen g , Elo Andersen h , Jens Overgaard j , Cai Grau c,e , Jeppe Friborg
doi : 10.1016/j.radonc.2023.109812
Volume 190, January 2024, 109812
Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma
Chia-Lun Chang a,b, Kuan-Chou Lin c,d, Wan-Ming Chen e,f, Ben-Chang Shia e,f, Szu-Yuan Wu
doi : 10.1016/j.radonc.2023.109971
Volume 190, January 2024, 109971
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group
Derek A Mumaw a,*, Allison J Hazy a, Aleksander Vayntraub a, Thomas J Quinn a, Kamran Salari a, John H Chang b, Noah Kalman c, Sanford Katz d, James Urbanic e, Robert H Press c, Arpi D Thukral f, Henry Tsai g, George E Laramore h, Jason Molitoris i, Carlos Vargas j, Samir H Patel j, Craig Stevens a, Rohan L Deraniyagala
doi : 10.1016/j.radonc.2023.109977
Volume 190, January 2024, 109977
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses
Elaine Limkin a, Pierre Blanchard a,b,c,*, Benjamin Lacas b,d, Jean Bourhis c,e, Mahesh Parmar f, Lisa Licitra g, Quynh-Thu Le h,i, Sue S. Yom i, Catherine Fortpied j, Johannes Langendijk k, Jan B Vermorken l, Jacques Bernier m, Jens Overgaard n, Jonathan Harris i, Jean- Pierre Pignon b,c,d, Anne Auperin b,c,d, on behalf of the MACH-NC* and MARCH** collaborative groups
doi : 10.1016/j.radonc.2023.110011
Volume 190, January 2024, 110011
Initial evaluation and external validation of 68Ga-PSMA-11 PET/CT in tubarial gland characterization
Luis Adrian Alvarez-Lozada a,1, Estefany Janeth Salinas-Puente b,1, Rodrigo Alejandro Torres-De Le´on a, Francisco Javier Arrambide-Garza a, Alejandro Quiroga-Garza a, Guillermo Elizondo-Riojas b, Rodrigo Enrique Elizondo-Oma?na a,*, Santos Guzm´an-L´opez a, Jos´e Luis Trevi?no-Gonzalez
doi : 10.1016/j.radonc.2023.109975
Volume 190, January 2024, 109975
Oral chemotherapy versus observation alone in nasopharyngeal carcinoma patients with persistently detected circulating cell-free Epstein-Barr virus DNA during follow-up
Cheng-Long Huang 1, Gao-Yuan Wang 1, Jia-Hao Lou 1, Lin Chen , Qing-Jie Li , Kun-Peng Li , Xiao-Yu Liang , Ying-Qin Li , Ying Sun , Jun Ma , Rui Guo , Ling-Long Tang 2, Lei Chen
doi : 10.1016/j.radonc.2023.110032
Volume 190, January 2024, 110032
A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma
Yong-Qiao He a,1, Tong-Min Wang a,1, Da-Wei Yang b,1, Wen-Qiong Xue a, Chang-Mi Deng a, Dan-Hua Li a, Wen-Li Zhang a, Ying Liao a, Ruo-Wen Xiao a, Lu-Ting Luo b, Hua Diao b, Xia-Ting Tong b, Yan-Xia Wu a, Xue-Yin Chen a, Jiang-Bo Zhang a, Ting Zhou a, Xi-Zhao Li a, Pei-Fen Zhang a, Xiao-Hui Zheng a, Shao-Dan Zhang a, Ye-Zhu Hu a, Guan-Qun Zhou c, Jun Ma c, Ying Sun c,*,2, Wei-Hua Jia
doi : 10.1016/j.radonc.2023.109974
Volume 190, January 2024, 109974
Progression of cognitive dysfunction in NPC survivors with radiation-induced brain necrosis: A prospective cohort
Yingying Zhu a,b,1, Jinping Cheng a,1, Yi Li a,1, Dong Pan c, Honghong Li a, Yongteng Xu a, Zhicheng Du d, Ming Lei a, Songhua Xiao a,2, Qingyu Shen a,2, Zhongshan Shi a,2, Yamei Tang
doi : 10.1016/j.radonc.2023.110033
Volume 190, January 2024, 110033
Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy
Lin Chen a,1, Jing Li b,1, Kunpeng Li a,1, Jiang Hu c, Qingjie Li a,d, Chenglong Huang a, Gaoyuan Wang a, Na Liu d,*, Linglong Tang
doi : 10.1016/j.radonc.2023.109985
Volume 190, January 2024, 109985
Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
Thuy-Tien Maria Huynh a,b,*, Einar Dale b, Ragnhild S?rum Falk c, Taran Paulsen Hellebust d,e, Guro Lindviksmoen Astrup b, Eirik Malinen d,e, Nina Frederike Jeppesen Edin d, Kristin Bjordal a,c, Bente Brokstad Herlofson f,g, Cecilie Essholt Kiserud b, ?slaug Helland a,b, Cecilie Delphin Amdal
doi : 10.1016/j.radonc.2023.110044
Volume 190, January 2024, 110044
Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center
Chlo´e Delerue a, David Pasquier a,b, Emilie Bogart c, Xavier Mirabel a, Julien Laffarguette d, S´everine Lals a, Ma¨el Barthoulot c, Eric Lartigau a, Xavier Liem
doi : 10.1016/j.radonc.2023.110029
Volume 190, January 2024, 110029
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity
Sara Ronchi a,*, Alessandro Cicchetti b, Maria Bonora a, Rossana Ingargiola a, Anna Maria Camarda a, Stefania Russo c, Sara Imparato d, Paolo Castelnuovo e,f, Ernesto Pasquini g, Piero Nicolai h, Mohssen Ansarin i, Michele Del Vecchio j, Marco Benazzo k, Ester Orlandi a,1, Barbara Vischioni
doi : 10.1016/j.radonc.2023.110003
Volume 190, January 2024, 110003
Sole brachytherapy for inoperable, recurrent, and irradiated salivary gland cancer
Yiwei Zhong , Xiaoming Lyu , Mingwei Huang , Lei Zheng , Shuming Liu , Yan Shi , Wenjie Wu , Jie Zhang , Jianguo Zhang
doi : 10.1016/j.radonc.2023.110022
Volume 190, January 2024, 110022
What is the predictive value of RECIST criteria following stereotactic lung radiation?
Stephanie Gulstene a, Pencilla Lang a, X. Melody Qu a, Joanna M. Laba a, Brian P. Yaremko a, George B. Rodrigues a, Edward Yu a, Mehdi Qiabi b, Rahul Nayak b, Richard A. Malthaner b, Dalilah Fortin b, Andrew Warner a,1, Richard I. Inculet b, David A. Palma
doi : 10.1016/j.radonc.2023.109976
Volume 190, January 2024, 109976
Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy
Albrecht Wei? a,b, Steffen L¨ock a,b,c, Ting Xu d, Zhongxing Liao d, Aswin L. Hoffmann b,c,f, Esther G.C. Troost
doi : 10.1016/j.radonc.2023.110013
Volume 190, January 2024, 110013
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation
Nikhil Yegya-Raman a,*, Sang Ho Lee a, Cole Friedes a, Xingmei Wang b, Michelle Iocolano a, Timothy P. Kegelman a,c, Lian Duan a, Bolin Li a, Eva Berlin a, Kristine N. Kim a, Abigail Doucette d, Srinivas Denduluri e, William P. Levin a, Keith A. Cengel a, Roger B. Cohen f, Corey J. Langer f, Boon-Keng Kevin Teo a, Wei Zou a, Rupal P. O’Quinn e, Joseph O. Deasy g, Jeffrey D. Bradley a, Lova Sun f, Bonnie Ky e, Ying Xiao a, Steven J. Feigenberg
doi : 10.1016/j.radonc.2023.110005
Volume 190, January 2024, 110005
“Primer shot� fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer
Z.A.R. Gouw a,c,*, J. Jeong a, A. Rimner b, N.Y. Lee b, A. Jackson a, A. Fu a, J-J. Sonke c, J.O. Deasy
doi : 10.1016/j.radonc.2023.110006
Volume 190, January 2024, 110006
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy
Francesco Cortiula a,b,*, Lizza E.L. Hendriks c, Robin Wijsman d, Ruud Houben a, Michelle Steens c, Sarah Debakker c, Richard Canters a, Marco Trov`o e, Nanna M. Sijtsema d, Anne G.H. Niezink d, Mirko Unipan a, Susanna Urban b, Anna Michelotti b, Safiye Dursun c, Gerben Bootsma f, Djoya Hattu a, Joost J. Nuyttens g, Eugenia Moretti h, Vicki T. Taasti a, Dirk De Ruysscher
doi : 10.1016/j.radonc.2023.110019
Volume 190, January 2024, 110019
The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
Cole Friedes a,*, Michelle Iocolano a, Sang Ho Lee b, Lian Duan b, Bolin Li b, Abigail Doucette a, Roger B. Cohen c, Charu Aggarwal c, Lova L. Sun c, William P. Levin a, Keith A. Cengel a, Gary Kao a, Boon-Keng Kevin Teo b, Corey J. Langer c, Ying Xiao b, Jeffrey Bradley a, Steven J. Feigenberg a, Nikhil Yegya-Raman
doi : 10.1016/j.radonc.2023.110030
Volume 190, January 2024, 110030
Widening the therapeutic window for central and ultra-central thoracic oligometastatic disease with stereotactic MR-guided adaptive radiation therapy (SMART)
Grace Lee a, Zhaohui Han a, Elizabeth Huynh b, Michael C Tjong a, Daniel N. Cagney c, Mai Anh Huynh a, Benjamin H. Kann a, David Kozono a, Jonathan E. Leeman a, Lisa Singer d, Christopher L. Williams a, Raymond H. Mak
doi : 10.1016/j.radonc.2023.110034
Volume 190, January 2024, 110034
Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials
Ilinca Popp a,*,1, Rianne D.W. Vaes b,1, Lotte Wieten c, Sonja Adebahr a, Lizza Hendriks d, Elham Bavafaye Haghighi e, Juliette Degens f, Henning Sch¨afer a, Christine Greil g, St´ephanie Peeters b, Cornelius F. Waller g, Ruud Houben b, Gabriele Niedermann a,h, Justyna Rawluk g, Eleni Gkika a, Justus Duyster g, Anca-Ligia Grosu a,h,2, Dirk De Ruysscher
doi : 10.1016/j.radonc.2023.110048
Volume 190, January 2024, 110048
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation
Geng-Min Niu a,1, Miao-Miao Gao a,1, Xiao-Feng Wang a, Yang Dong a, Yi-Fan Zhang b, Huan-Huan Wang a, Yong Guan a, Ze-Yuan Cheng a, Shu-Zhou Zhao a, Yong-Chun Song a, Zhen Tao a, Lu-Jun Zhao a, Mao-Bin Meng a, Feng-Ming Spring Kong c,*, Zhi-Yong Yuan
doi : 10.1016/j.radonc.2023.110023
Volume 190, January 2024, 110023
Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach
A. Gomez-Iturriaga a,*, L. Zaragoza a, I. Valverde a, F. Perez Azorin a, B. Santos-Zorrozua b, J.A. Guerrero a, F. Cou?nago c, J. Cacicedo a, M. Marban a, S. Santana d, C. Mascarell a, E. Novo e, R. Fernandez e, J. Garcia-Olaverri f, A. Urresola g, A. Ezquerro g, D. Büchser
doi : 10.1016/j.radonc.2023.110024
Volume 190, January 2024, 110024
Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity
Luca Nicosia a,*, Paolo Ravelli a, Michele Rigo a, Niccol`o Giaj-Levra a, Rosario Mazzola a, Edoardo Pastorello a, Francesco Ricchetti a, Andrea Gaetano Allegra a, Ruggero Ruggieri a, Filippo Alongi
doi : 10.1016/j.radonc.2023.110043
Volume 190, January 2024, 110043
Paediatric CBCT protocols for image-guided radiotherapy; outcome of a survey across SIOP Europe affiliated countries and literature review
Daniella Elisabet ?stergaard a,b,1,*, Abigail Bryce-Atkinson c,1, Mikkel Skaarup a, Bob Smulders a,d, Lucy Siew Chen Davies e, Gillian Whitfield f,g, Geert O. Janssens h,i, Lisa Lyngsie Hjalgrim j, Ivan Vogelius Richter a,b, Marcel van Herk c, Marianne Aznar c,1, Maja Vestm? Maraldo
doi : 10.1016/j.radonc.2023.109963
Volume 190, January 2024, 109963
Improved local control following dose-escalated stereotactic ablative radiation therapy (SABR) for metastatic sarcomas: An international multi-institutional experience
Raj Singh a,*,1, Alec Konrad b, John G. Roubil c, Jan Jenkins d, Joanne Davis d, John Austin Vargo e, Emile Gogineni a, Sanjeev Sharma
doi : 10.1016/j.radonc.2023.110020
Volume 190, January 2024, 110020
Treatment planning comparison for head and neck cancer between photon, proton, and combined proton–photon therapy – From a fixed beam line to an arc
Florian Amstutz a,b, Reinhardt Krcek a,d, Barbara Bachtiary a, Damien C. Weber a,c,d, Antony J. Lomax a,b, Jan Unkelbach c, Ye Zhang
doi : 10.1016/j.radonc.2023.109973
Volume 190, January 2024, 109973
Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
Maria Thor a,*,1, Kelly Fitzgerald b,1, Aditya Apte a, Jung Hun Oh a, Aditi Iyer a, Otasowie Odiase b, Saad Nadeem a, Ellen D. Yorke a, Jamie Chaft c, Abraham J. Wu b, Michael Offin c, Charles B Simone II b, Isabel Preeshagul c, Daphna Y. Gelblum b, Daniel Gomez b, Joseph O. Deasy a, Andreas Rimner
doi : 10.1016/j.radonc.2023.109983
Volume 190, January 2024, 109983
Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques
Dominique Reijtenbagh a,*, J´er´emy Godart a, Joan Penninkhof a, Sandra Quint a, Andr´as Zolnay a, Jan-Willem Mens a, Mischa Hoogeman
doi : 10.1016/j.radonc.2023.110009
Volume 190, January 2024, 110009
A multimodality assessment of the protective capacity of statin therapy in a mouse model of radiation cardiotoxicity
Gerard M. Walls a,b,*, Mihaela Ghita b, Brian Herron c, Kevin S. Edgar d, Refik Kuburas b, Chris J Watson d, David J. Grieve d, Aidan J. Cole a,b, Suneil Jain a,b, Karl T. Butterworth
doi : 10.1016/j.radonc.2023.110004
Volume 190, January 2024, 110004
Radio-chemotherapy of glioblastoma cells promotes phagocytosis by macrophages in vitro
Marc Lecoultre a,b,d, Sylvie Chliate a,b, Felipe I. Espinoza a,b, Stoyan Tankov a,b, Val´erie Dutoit a,b,c, Paul R. Walker
doi : 10.1016/j.radonc.2023.110049
Volume 190, January 2024, 110049
Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis
Jianping Bi a,b,1, Rui Meng c,1, Dongqin Yang d,1, Ying Li a,1, Jun Cai e, Li Zhang f, Jing Qian g, Xudong Xue a, Shiqi Hu h, Zilong Yuan i, Vivek Verma j, Nan Bi k,*, Guang Han
doi : 10.1016/j.radonc.2023.110040
Volume 190, January 2024, 110040
Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy
Tingting Nie a,1, Zien Chen a,b,1, Jun Cai c,1, Shuangquan Ai a,b, Xudong Xue d, Mengting Yuan d, Chao Li c, Liting Shi e,f, Yulin Liu a, Vivek Verma g, Jianping Bi d,*, Guang Han d,*, Zilong Yuan
doi : 10.1016/j.radonc.2023.110047
Volume 190, January 2024, 110047
Pilot applications of GPT-4 in radiation oncology: Summarizing patient symptom intake and targeted chatbot applications
David JH Wu a, Jean-Emmanuel Bibault
doi : 10.1016/j.radonc.2023.109978
Volume 190, January 2024, 109978
Dosimetric and biologic intercomparison between electron and proton FLASH beams
A Almeida a,1, M Togno b,1, P Ballesteros-Zebadua a,f,1, J Franco-Perez a,f, R Geyer c, R Schaefer b, B Petit a, V Grilj e, D Meer b, S Safai b, T Lomax b, DC Weber b,c,d, C Bailat e,2, S Psoroulas b,2, Marie-Catherine Vozenin
doi : 10.1016/j.radonc.2023.109953
Volume 190, January 2024, 109953
FLASH radiotherapy using high-energy X-rays: Current status of PARTER platform in FLASH research
Yiwei Yang a,1,**, Jianxin Wang a,1, Feng Gao b,1, Zhen Liu c, Tangzhi Dai b, Haowen Zhang d, Hongyu Zhu e, Tingting Wang b, Dexin Xiao a, Kui Zhou a, Zheng Zhou a, Dai Wu a, Xiaobo Du b,**, Sen Bai
doi : 10.1016/j.radonc.2023.109967
Volume 190, January 2024, 109967
GABARAPL1 is essential in extracellular vesicle cargo loading and metastasis development
Joel E.J. Beaumont a, Jinzhe Ju a, Lydie M.O. Barbeau a, Imke Demers a,b, Kim G. Savelkouls a, Kasper Derks c, Freek G. Bouwman d, Marca H.M. Wauben e, Marijke I. Zonneveld a, Tom G. H. Keulers a, Kasper M.A. Rouschop
doi : 10.1016/j.radonc.2023.109968
Volume 190, January 2024, 109968
Mesenchymal stem cell-derived HGF attenuates radiation-induced senescence in salivary glands via compensatory proliferation
A. Soto-Gamez a,b, M. van Es a,b, E. Hageman a,b, S.A. Serna-Salas c, H. Moshage c, M. Demaria d, S. Pringle e, R.P. Coppes
doi : 10.1016/j.radonc.2023.109984
Volume 190, January 2024, 109984
Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model
Jun Yeong Song a,†, Min Guk Han d, Yoomin Kim c,d, Min Ji Kim c, Mi Hyun Kang d, Seung Hyuck Jeon b,d, In Ah Kim
doi : 10.1016/j.radonc.2023.109981
Volume 190, January 2024, 109981
Caffeic Acid Phenethyl Ester (CAPE), a natural polyphenol to increase the therapeutic window for lung adenocarcinomas
E. Prades-Sagarra a, F. Laarakker a, J. Dissy a, N.G. Lieuwes a, R. Biemans a, M. Dubail b, C. Fouillade b, A. Yaromina a,1, L.J. Dubois
doi : 10.1016/j.radonc.2023.110021
Volume 190, January 2024, 110021
Mitophagy induction improves salivary gland stem/progenitor cell function by reducing senescence after irradiation
Davide Cinat a,b, Anna Lena De Souza a,b,1, Abel Soto-Gamez a,b,1, Anne L. Jellema-de Bruin a,b, Rob P. Coppes a,b, Lara Barazzuol
doi : 10.1016/j.radonc.2023.110028
Volume 190, January 2024, 110028
Targeting the survival kinase DYRK1B: A novel approach to overcome radiotherapy-related treatment resistance
Claire Beckers , Lazaros Vasilikos , Alba Sanchez Fernandez , Lorena Moor , Martin Pruschy
doi : 10.1016/j.radonc.2023.110039
Volume 190, January 2024, 110039
Assessing late outcomes of advances in radiotherapy for paediatric cancers: Study protocol of the “HARMONIC-RT� European registry (NCT 04746729)
doi : 10.1016/j.radonc.2023.109972
Volume 190, January 2024, 109972
ChatGPT and research in radiation oncology: Correspondence
Hinpetch Daungsupawong
doi : 10.1016/j.radonc.2023.110037
Volume 190, January 2024, 110037
Evidence is not sufficient to declare the tubal gland conglomerates as salivary
Ashutosh Kumara, Ravi Kant Narayanb,*, Chiman Kumaric
doi : 10.1016/j.radonc.2023.109960
Volume 190, January 2024, 109960
Away from definition and back to the clinic – As response to Kumar et al, ‘Evidence is not sufficient to declare the tubal gland conglomerates as salivary’
Sarah Pringle
doi : 10.1016/j.radonc.2023.109959
Volume 190, January 2024, 109959
Letter regarding “Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy�
Gavin Poludniowskia,b,*, Jens Zimmerman
doi : 10.1016/j.radonc.2023.109962
Volume 190, January 2024, 109962
Response to “Letter regarding Consensus guide on CT-based prediction of stopping-power ratio using a Hounsfield look-up table for proton therapy�
Nils Petersa,b,*,1, Vicki Trier Taastic,*,1, Benjamin Ackermannd,2, Alessandra Bolsie,2, Christina Vallhagen Dahlgrenf,2, Malte Ellerbrockd,2, Francesco Fracchiollag,2, Carles Gom`ah,2, Joanna G´orai,2, Patricia Cambraia Lopesj,2, Ilaria Rinaldic,2, Koen Salvok,2, Ivanka Sojat Tarpl,2, Alessandro Vaim,2, Thomas Bortfeldb, Antony Lomaxe, Christian Richtera,n,o,p, Patrick Wohlfahrt
doi : 10.1016/j.radonc.2023.109961
Volume 190, January 2024, 109961
On the advice to perform a new MRI within 2Â weeks prior to radiotherapy start for glioblastoma according ESTRO-EANO guideline
doi : 10.1016/j.radonc.2023.109964
Volume 190, January 2024, 109964
Response to the letter to the editor by Macià i Garau et al. regarding the article “ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma� by Niyazi et al.
Maximilian Niyazi
doi : 10.1016/j.radonc.2023.109965
Volume 190, January 2024, 109965
Comment on: The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer
Efsun Somay
doi : 10.1016/j.radonc.2023.110025
Volume 190, January 2024, 110025
Response to: Comment on: The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer
doi : 10.1016/j.radonc.2023.110026
Volume 190, January 2024, 110026
Comments on “Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment�
doi : 10.1016/j.radonc.2023.110035
Volume 190, January 2024, 110035
Response to the letter-to-the-editor “Comments on: Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment�
doi : 10.1016/j.radonc.2023.110036
Volume 190, January 2024, 110036
